TARO RECEIVES NASDAQ NOTICE OF POSSIBLE DELISTING FOR DELAYED FILING OF 2005 FORM 20-F

Taro Pharmaceutical Industries Ltd. reported today that on July 19, 2006 it received a Staff Determination from the Listing Qualifications Department of The Nasdaq Stock Market. Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=3504459)